Acticor Biotech (XPAR:ALACT) Total Stockholders Equity : €0.37 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Total Stockholders Equity?

Acticor Biotech's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €0.37 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Acticor Biotech's Book Value per Share for the quarter that ended in Jun. 2023 was €0.03. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Acticor Biotech's Debt-to-Equity for the quarter that ended in Jun. 2023 was 19.15.

Acticor Biotech Total Stockholders Equity Historical Data

The historical data trend for Acticor Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Total Stockholders Equity Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

6.24

9.03

1.72

11.02

-2.24

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial				4.11	11.02	4.31	-2.24	0.37

Acticor Biotech (XPAR:ALACT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Acticor Biotech's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.368	-	0)	/	12.2954
	=	0.03

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Acticor Biotech's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.705	+	4.342)	/	0.368
	=	19.15

Acticor Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines